Key Takeaways For obvious reasonssafety, discomfort, and the potential for an underlying or worsening problempersistent or recurrent dizziness should not be ignored
In addition to that, they also suppress appetite centers in the brain, so people feel satiety. Advertisement Article continues below this ad The first authorization for GLP-1 use in weight loss came in 2014, when Novo Nordisks Saxenda gained approval, and more authorizations for updated medications followed
Administered through injectable pens like Ozempic and Wegovy, semaglutide is convenient for self-use
We know what you're thinking: "I use SPF, I don't need any more sun protection..." But we've got news for you: You actually DO need more sun protection
Our guide to GLP-1 for Hashimoto disease covers the clinical rationale and practical considerations
All participants were compulsory hospitalized during 2-days pre-fasting and during 5-days fasting period